Centene Stock Forecast for 2023 - 2025 - 2030
Updated on 04/23/2024
Centene Stock Forecast and Price Target
If Centene's stock price reached the average yearlong target of $90.00 given by eleven well-known analysts in recent months, there would be a potential upside of approximately 19.08% from its last closing price in April, 2024. This potential increase is based on a high estimate of $110.00 and a low estimate of $73.30. If interested in CNC stock, you may also want to consider its competitors.
19.08% Upside
Centene Fair Value Forecast for 2023 - 2025 - 2030
Centene's Price has decreased by 100.00% In the last four years, from $66.35 to $0.00. In the next year, analysts believe that Fair Value will reach $101.52 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| UNH Stock Forecast | UnitedHealth Group | Buy |
16
|
$491.23 | Buy/Sell | $595.09 | 14.41% |
| ELV Stock Forecast | Elevance Health | Buy |
14
|
$532.22 | Buy/Sell | $567.53 | 12.74% |
| CI Stock Forecast | The Cigna Group | Outperform |
12
|
$353.18 | Buy/Sell | $354.48 | 9.01% |
| CVS Stock Forecast | CVS Health | Outperform |
12
|
$69.63 | Buy/Sell | $89.54 | 26.10% |
| HCA Stock Forecast | HCA Healthcare | Outperform |
18
|
$310.31 | Buy/Sell | $319.61 | 10.76% |
Centene Revenue Forecast for 2023 - 2025 - 2030
Centene's Revenue has seen impressive growth In the last three years, rising from $104.18B to $141.27B – a growth of 35.60%. In the next year, analysts believe that Revenue will reach $149.98B – an increase of 6.17%. For the next seven years, the forecast is for Revenue to grow by 34.13%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HUM Stock Forecast | Humana | Outperform |
14
|
$325.30 | Buy/Sell | $426.74 | 18.35% |
| CAH Stock Forecast | Cardinal Health Inc | Hold |
13
|
$102.83 | Buy/Sell | $108.07 | 11.84% |
| MOH Stock Forecast | Molina Healthcare | Outperform |
16
|
$361.87 | Buy/Sell | $393.38 | 15.61% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DVA Stock Forecast | DaVita Inc | Hold |
16
|
$132.52 | Buy/Sell | $108.38 | 0.36% |
| UHS Stock Forecast | Universal Health Services | Outperform |
6
|
$161.13 | Buy/Sell | $162.38 | 16.06% |
| CHE Stock Forecast | Chemed Corp | Outperform |
18
|
$604.42 | Buy/Sell | $611.33 | 15.23% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| THC Stock Forecast | Tenet Healthcare | Outperform |
15
|
$94.85 | Buy/Sell | $86.63 | 19.14% |
| ACHC Stock Forecast | Acadia Healthcare Company | Outperform |
15
|
$70.26 | Buy/Sell | $89.55 | 42.33% |
| EHC Stock Forecast | Encompass Health | Buy |
18
|
$80.33 | Buy/Sell | $85.22 | 12.04% |
Centene EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Centene's EBITDA has seen an increase, rising from $5.37B to $6.08B. This represents a growth of 13.22%. Analysts predict that Centene's EBITDA will increase in the upcoming year, reaching $7.25B. This would represent an increase of 19.24%. Over the next seven years, experts predict that Centene's EBITDA will grow at a rate of 7.66%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ENSG Stock Forecast | The Ensign Group | Outperform |
18
|
$117.23 | Buy/Sell | $119.25 | 13.45% |
| OPCH Stock Forecast | Option Care Health | Buy |
14
|
$30.41 | Buy/Sell | $0.00 | 27.59% |
| SEM Stock Forecast | Select Medical Holdings | Outperform |
16
|
$27.33 | Buy/Sell | $32.80 | 31.72% |
Centene EBIT Forecast for 2023 - 2025 - 2030
Centene's EBIT has seen growth In the last three years, going from $4.11B to $4.79B – a gain of 16.45% In the next year, analysts believe that EBIT will reach $6.08B – an increase of 27.06%. For the next seven years, the forecast is forEBIT to grow by 51.50%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SGRY Stock Forecast | Surgery Partners | Buy |
13
|
$24.04 | Buy/Sell | $43.20 | 78.87% |
| AMED Stock Forecast | Amedisys | Hold |
16
|
$91.24 | Buy/Sell | $97.00 | 10.70% |
| AMN Stock Forecast | AMN Healthcare Services | Outperform |
16
|
$56.51 | Buy/Sell | $86.13 | 30.95% |
Centene EPS Price Prediction Forecast for 2023 - 2025 - 2030
Centene's EPS has decreased by 100.00% In the last four years, from $5.00 to $0.00. In the next year, analysts believe that EPS will reach $7.65 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BKD Stock Forecast | Brookdale Senior Living | Outperform |
10
|
$6.60 | Buy/Sell | $6.48 | 17.42% |
| MD Stock Forecast | Pediatrix Medical Group | Hold |
12
|
$9.03 | Buy/Sell | $9.86 | -0.33% |
| CYH Stock Forecast | Community Health Systems | Outperform |
11
|
$2.84 | Buy/Sell | $4.98 | 49.65% |
.jpg)